Complete FDA and NHTSA recall records dated in 2025, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Chrysler (FCA US, LLC) is recalling certain 2025-2026 Ram 1500 Pickup, Ram 2500 Pickup, Ram 3500 Pickup, Ram 3500 Cab Chassis, 4500 Ram Cab Chassis, and Ram 5500 Cab Chassis vehicles. A…
Chrysler (FCA US, LLC) is recalling certain 2019 Ram 1500 Classic, Ram 2500, and Ram 3500 vehicles. The right and left side curtain air bag inflators may rupture due to a manufacturing…
Ford Motor Company (Ford) is recalling certain 2025 Lincoln Navigator, F-150, Expedition, Bronco, and Ranger vehicles. The Electronic Brake Booster (EBB) module may malfunction while…
Raw milk Peppercorn cheese is recalled due to E.coli O26:H11
Item #28855 Whatcom Blue is recalled due to E. coli O103:H2
Elevated levels of lead in Cinnamon powder.
Raw milk Farmhouse cheeses are recalled due to E. coli O103:H2 and E. coli O74:H25.
Raw milk Mustard Seed cheese is recalled due to E. coli O103:H2 and E. coli O74:H25.
Item #29608 Farmhouse White is recalled due to E. coli O103:H2.
Raw milk Whatcom Blue cheese is recalled due to E. coli O103:H2.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.
Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.
